116 related articles for article (PubMed ID: 15005878)
1. Pharmacological characterization and identification of EP3 prostanoid receptor binding sites in hamster uterus homogenates.
Sharif NA; Xu SX
J Pharm Pharmacol; 2004 Feb; 56(2):197-203. PubMed ID: 15005878
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
[TBL] [Abstract][Full Text] [Related]
3. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
Davis TL; Sharif NA
Br J Pharmacol; 2000 Aug; 130(8):1919-26. PubMed ID: 10952683
[TBL] [Abstract][Full Text] [Related]
5. Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes.
Mechiche H; Grassin-Delyle S; Robinet A; Nazeyrollas P; Devillier P
PLoS One; 2012; 7(9):e45273. PubMed ID: 22984630
[TBL] [Abstract][Full Text] [Related]
6. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
Sharif NA; Davis TL
J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
[TBL] [Abstract][Full Text] [Related]
7. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
[TBL] [Abstract][Full Text] [Related]
8. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
9. Excitatory action of prostanoids on the ferret isolated vagus nerve preparation.
Kan KK; Jones RL; Ngan MP; Rudd JA
Eur J Pharmacol; 2004 Apr; 491(1):37-41. PubMed ID: 15102531
[TBL] [Abstract][Full Text] [Related]
10. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
Walch L; Clavarino E; Morris PL
Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium.
Senior J; Marshall K; Sangha R; Baxter GS; Clayton JK
Br J Pharmacol; 1991 Mar; 102(3):747-53. PubMed ID: 1285399
[TBL] [Abstract][Full Text] [Related]
13. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
Sharif NA; Crider JY; Xu SX; Williams GW
J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
[TBL] [Abstract][Full Text] [Related]
14. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.
Clarke DL; Giembycz MA; Patel HJ; Belvisi MG
Br J Pharmacol; 2004 Feb; 141(4):600-9. PubMed ID: 14744812
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
16. TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor.
Negishi M; Harazono A; Sugimoto Y; Hazato A; Kurozumi S; Ichikawa A
Prostaglandins; 1994 Nov; 48(5):275-83. PubMed ID: 7855308
[TBL] [Abstract][Full Text] [Related]
17. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
[TBL] [Abstract][Full Text] [Related]
18. Characterization of prostanoid receptors present on adrenergic neurons innervating the porcine uterine longitudinal muscle.
Cao J; Nakamura T; Kitazawa T; Yamashiki N; Yamamoto T; Taneike T
Prostaglandins Other Lipid Mediat; 2008 Jun; 86(1-4):26-34. PubMed ID: 18403225
[TBL] [Abstract][Full Text] [Related]
19. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
[TBL] [Abstract][Full Text] [Related]
20. Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization.
Crider JY; Griffin BW; Sharif NA
Prostaglandins Leukot Essent Fatty Acids; 2000 Jan; 62(1):21-6. PubMed ID: 10765975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
